Advanced Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
UC San Diego Health System is an internationally recognized referral center for the evaluation and treatment of patients with chronic thromboembolic pulmonary vascular disease and all forms of pulmonary hypertension.
Pulmonary vascular diseases affect the blood vessels between the heart and the lungs.
Our Pulmonary Vascular Medicine program conducts research and offers one-stop for diagnosis, consultation and state-of-the-art treatment for patients with all forms of pulmonary vascular disease. Led by Nick H. Kim, MD, the program emphasizes leading-edge treatments in pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Both PAH and CTEPH are rare and deadly, but also treatable. Read more about these services through the links below.
Why Choose UC San Diego Pulmonary Vascular Medicine?
CBS 8: UC San Diego's lifesaving pulmonary thromboendarterectomy (PTE) surgery